NCT03143192View on ClinicalTrials.gov

Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

May 9, 2019

Study Completion Date

May 9, 2019

Conditions
Diabetic Macular Edema
Interventions
COMBINATION_PRODUCT

Micropulse Laser

Aflibercept injection with Micropulse laser.

DEVICE

Sham Laser

Aflibercept injection with Sham Laser

Trial Locations (2)

L4X 2Z9

Mississauga Retina Institute, Mississauga

M3C 0G9

Toronto Retina Institute, Toronto

All Listed Sponsors
lead

Keyvan Koushan

OTHER

NCT03143192 - Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser | Biotech Hunter | Biotech Hunter